Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
48 NC counties and 1 VA county are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Just In
WRAL Weather Alert Day: Several downed trees reported along I-40 westbound in Wake County as storms move through central NC
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hikma Pharmaceuticals Plc ADR
(OP:
HKMPY
)
55.56
+3.86 (+7.47%)
Streaming Delayed Price
Updated: 9:54 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
399
Open
54.00
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
51.70
Today's Range
54.00 - 55.56
52wk Range
42.23 - 55.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
January 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
June 12, 2023
The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...
Via
Benzinga
Performance
YTD
+22.30%
+22.30%
1 Month
+12.62%
+12.62%
3 Month
+11.59%
+11.59%
6 Month
+7.57%
+7.57%
1 Year
+5.89%
+5.89%
More News
Read More
Junshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa Region
December 26, 2022
From
Junshi Biosciences
Via
GlobeNewswire
Friday Markets News
March 25, 2022
Via
Talk Markets
Bio-Thera Solutions and Hikma Pharmaceuticals Announce Exclusive Commercialization and License Agreement for BAT2206 in the US, a Proposed Biosimilar Referencing Stelara® (ustekinumab)
August 27, 2021
From
Bio-Thera Solutions, Ltd.
Via
Business Wire
Summer Friday
June 25, 2021
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.